Dr. Shyam Bishen is a senior healthcare executive with over 25 years of global experience in healthcare public-private partnership, strategy development, M&A, and business development. He comes to the Forum from Bill and Melinda Gates Foundation in Seattle where he was a regional/deputy director for seven years and was responsible for partnering to harness advances in healthcare to save lives. Before moving to Gates Foundation, he spent more than 20 years in private sector, and most recently headed up emerging markets strategy & innovation at Merck (MSD) in New Jersey as vice president and general manager. Prior to joining the corporate sector, Dr. Bishen was in academia and worked as an Assistant Professor at the Medical University of South Carolina in Charleston. He is qualified with a Ph.D. from the University of Newcastle and an MBA from Washington University in St. Louis.
A blood test has been shown to detect Parkinson's disease in a preliminary study, giving hope that doctors may be able to detect the condition at an earlier stage in the future.
Climate change is creating an unprecedented threat to human health. As earth’s average surface temperature continues to rise, natural catastrophes and extreme weather events will become m...
Research is underway to determine the risks posed by a new form of coronavirus that has been found around the world. The variant has been detected by several laboratories and appears to b...
The number of steps you need to walk each day to start seeing health benefits is lower than previously thought, a new study suggests.
UN health innovation agency Unitaid has warned that failing to implement contact tracing and prevention measures for tuberculosis could lead to close to a million deaths by 2035.
Un nuevo fármaco contra el Alzheimer, el donanemab, ha demostrado ralentizar en un 35% el deterioro cognitivo de los pacientes de un ensayo mundial.
A new Alzheimer's drug, donanemab, has been shown to slow cognitive decline in patients in a global trial by 35%.
A health alert has been issued in the US after a handful of locally transmitted cases of malaria were identified in the country. The cases in Texas and Florida are the first to have sprea...
From predicting which patients are most likely to develop heart disease to creating personalised cancer vaccines, artificial intelligence (AI) is adding new capabilities to the health sec...
La brecha mundial de género en materia de salud y supervivencia ha mejorado el pasado año, y es una de las más estrechas medidas por el Informe sobre la Brecha de Género 2023 del Foro Eco...
The global gender gap on health and survival has improved year-on-year, and is one of the narrowest gaps measured by the World Economic Forum's Gender Gap Report 2023.
A trial of a new vaccine against meningococcal disease, a cause of meningitis and blood poisoning, has seen positive results against five strains of meningococcal bacteria – A, C, W, Y an...
The World Health Assembly (WHA) is an annual event in Geneva, Switzerland, that the World Health Organization’s (WHO) decision-making body holds to convene WHO member states to determine ...
The World Health Organization (WHO) has declared that the outbreak of the Mpox virus which began around a year ago is no longer a public health emergency of international concern.
The World Health Organization (WHO) ended the global emergency status for COVID-19 on 5 May, more than three years after its original declaration, and said countries should now manage the...
